Share

Hoofnagle, Jay H. us

List of all publications

Publishing since 1973 (Dinosaur)

    2010

  1. Journal Article Feld JJ, Lutchman GA, Heller T, Hara K, Pfeiffer JK, Leff RD, Meek C, Rivera M, Ko M, Koh C, Rotman Y, Ghany MG, Haynes-Williams V, Neumann AU, Liang TJ, Hoofnagle JH. Ribavirin improves early responses to peginterferon through enhanced interferon signaling.  Gastroenterology  2010  Link to Ribavirin improves early responses to peginterferon through enhanced interferon signaling.
  2. Journal Article Agarwal VK, McHutchison JG, Hoofnagle JH. Important Elements for the Diagnosis of Drug-Induced Liver Injury.  Clin. Gastroenterol. Hepatol.  2010  Link to Important Elements for the Diagnosis of Drug-Induced Liver Injury.
  3. Journal Article Rotman Y, Borg BB, Soza A, Feld JJ, Modi AA, Loomba R, Lutchman G, Rivera E, Doo E, Ghany MG, Heller T, Neumann AU, Liang TJ, Hoofnagle JH. Clinical trial: low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3 - efficacy, tolerability, viral kinetics and cytokine response.  Aliment. Pharmacol. Ther.  2010  Link to Clinical trial: low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3 - efficacy, tolerability, viral kinetics and cytokine response.
  4. Journal Article Modi AA, Feld JJ, Park Y, Kleiner DE, Everhart JE, Liang TJ, Hoofnagle JH. Increased caffeine consumption is associated with reduced hepatic fibrosis.  Hepatology  2010;51;1  Link to Increased caffeine consumption is associated with reduced hepatic fibrosis.
  5. Journal Article Ahlenstiel G, Titerence RH, Koh C, Edlich B, Feld JJ, Rotman Y, Ghany MG, Hoofnagle JH, Liang TJ, Heller T, Rehermann B. Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.  Gastroenterology  2010;138;1  Link to Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.

    6. 2009

  6. Case ReportsJournal ArticleResearch Support, N.I.H., ExtramuralResearch Support, N.I.H., Intramural Palmore TN, Shah NL, Loomba R, Borg BB, Lopatin U, Feld JJ, Khokhar F, Lutchman G, Kleiner DE, Young NS, Childs R, Barrett AJ, Liang TJ, Hoofnagle JH, Heller T. Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression.  Clin. Gastroenterol. Hepatol.  2009;7;10  Link to Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression.
  7. Journal ArticleMulticenter StudyResearch Support, N.I.H., ExtramuralResearch Support, N.I.H., Intramural Dove LM, Rosen RC, Ramcharran D, Wahed AS, Belle SH, Brown RS, Hoofnagle JH. Decline in male sexual desire, function, and satisfaction during and after antiviral therapy for chronic hepatitis C.  Gastroenterology  2009;137;3  Link to Decline in male sexual desire, function, and satisfaction during and after antiviral therapy for chronic hepatitis C.
  8. Consensus Development Conference, NIHJournal ArticleResearch Support, N.I.H., Extramural Rotman Y, Brown TA, Hoofnagle JH. Evaluation of the patient with hepatitis B.  Hepatology  2009;49;5 Suppl  Link to Evaluation of the patient with hepatitis B.
  9. Congresses Doo EC, Hoofnagle JH, Rodgers GP. NIH consensus development conference: management of Hepatitis B. Introduction.  Hepatology  2009;49;5 Suppl  Link to NIH consensus development conference: management of Hepatitis B. Introduction.
  10. Consensus Development Conference, NIHJournal ArticleResearch Support, N.I.H., Extramural Doo EC, Hoofnagle JH. The hepatitis B research network.  Hepatology  2009;49;5 Suppl  Link to The hepatitis B research network.
  11. Consensus Development Conference, NIHJournal ArticleResearch Support, N.I.H., Extramural Hoofnagle JH. Reactivation of hepatitis B.  Hepatology  2009;49;5 Suppl  Link to Reactivation of hepatitis B.
  12. CommentEditorial Hoofnagle JH. A step forward in therapy for hepatitis C.  N. Engl. J. Med.  2009;360;18  Link to A step forward in therapy for hepatitis C.
  13. Clinical TrialJournal ArticleMulticenter StudyResearch Support, N.I.H., Extramural Hoofnagle JH, Wahed AS, Brown RS, Howell CD, Belle SH. Early changes in hepatitis C virus (HCV) levels in response to peginterferon and ribavirin treatment in patients with chronic HCV genotype 1 infection.  J. Infect. Dis.  2009;199;8  Link to Early changes in hepatitis C virus (HCV) levels in response to peginterferon and ribavirin treatment in patients with chronic HCV genotype 1 infection.

    14. 2008

  14. Comparative StudyJournal ArticleResearch Support, N.I.H., ExtramuralResearch Support, N.I.H., Intramural Terrault NA, Im K, Boylan R, Bacchetti P, Kleiner DE, Fontana RJ, Hoofnagle JH, Belle SH. Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C.  Clin. Gastroenterol. Hepatol.  2008;6;12  Link to Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C.
  15. Journal Article Loomba R, Lutchman G, Kleiner DE, Ricks M, Feld JJ, Borg BB, Modi A, Nagabhyru P, Sumner AE, Liang TJ, Hoofnagle JH. Clinical trial: Pilot study of metformin for the treatment of nonalcoholic steatohepatitis.  Aliment. Pharmacol. Ther.  2008  Link to Clinical trial: Pilot study of metformin for the treatment of nonalcoholic steatohepatitis.
  16. Journal ArticleResearch Support, N.I.H., Intramural Feld JJ, Hussain N, Wright EC, Kleiner DE, Hoofnagle JH, Ahlawat S, Anderson V, Hilligoss D, Gallin JI, Liang TJ, Malech HL, Holland SM, Heller T. Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease.  Gastroenterology  2008;134;7  Link to Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease.
  17. Comparative StudyJournal ArticleResearch Support, N.I.H., Extramural Howell CD, Dowling TC, Paul M, Wahed AS, Terrault NA, Taylor M, Jeffers L, Hoofnagle JH. Peginterferon pharmacokinetics in African American and Caucasian American patients with hepatitis C virus genotype 1 infection.  Clin. Gastroenterol. Hepatol.  2008;6;5  Link to Peginterferon pharmacokinetics in African American and Caucasian American patients with hepatitis C virus genotype 1 infection.
  18. Journal ArticleResearch Support, N.I.H., IntramuralReview Loomba R, Rowley A, Wesley R, Liang TJ, Hoofnagle JH, Pucino F, Csako G. Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy.  Ann. Intern. Med.  2008;148;7  Link to Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy.
  19. Clinical ConferenceJournal ArticleResearch Support, N.I.H., Extramural Lee WM, Squires RH, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: Summary of a workshop.  Hepatology  2008;47;4  Link to Acute liver failure: Summary of a workshop.
  20. CongressesResearch Support, N.I.H., ExtramuralResearch Support, N.I.H., Intramural Chung RT, Gale M, Polyak SJ, Lemon SM, Liang TJ, Hoofnagle JH. Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop.  Hepatology  2008;47;1  Link to Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop.

    21. 2007

  21. CommentEditorialResearch Support, N.I.H., Intramural Modi AA, Hoofnagle JH. New therapies for hepatitis C.  Hepatology  2007;46;3  Link to New therapies for hepatitis C.
  22. Journal ArticleResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, P.H.S.Review Sokol RJ, Shepherd RW, Superina R, Bezerra JA, Robuck P, Hoofnagle JH. Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop.  Hepatology  2007;46;2  Link to Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop.
  23. Journal ArticleResearch Support, N.I.H., Intramural Lutchman G, Modi A, Kleiner DE, Promrat K, Heller T, Ghany M, Borg B, Loomba R, Liang TJ, Premkumar A, Hoofnagle JH. The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis.  Hepatology  2007;46;2  Link to The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis.
  24. Journal ArticleRandomized Controlled TrialResearch Support, N.I.H., Intramural Lutchman G, Danehower S, Song BC, Liang TJ, Hoofnagle JH, Thomson M, Ghany MG. Mutation rate of the hepatitis C virus NS5B in patients undergoing treatment with ribavirin monotherapy.  Gastroenterology  2007;132;5  Link to Mutation rate of the hepatitis C virus NS5B in patients undergoing treatment with ribavirin monotherapy.
  25. Clinical ConferenceJournal ArticleResearch Support, N.I.H., IntramuralReview Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS. Management of hepatitis B: summary of a clinical research workshop.  Hepatology  2007;45;4  Link to Management of hepatitis B: summary of a clinical research workshop.
  26. Journal ArticleResearch Support, N.I.H., Intramural Hussain N, Feld JJ, Kleiner DE, Hoofnagle JH, Garcia-Eulate R, Ahlawat S, Koziel DE, Anderson V, Hilligoss D, Choyke P, Gallin JI, Liang TJ, Malech HL, Holland SM, Heller T. Hepatic abnormalities in patients with chronic granulomatous disease.  Hepatology  2007;45;3  Link to Hepatic abnormalities in patients with chronic granulomatous disease.
  27. Comparative StudyEvaluation StudiesJournal ArticleMulticenter StudyResearch Support, N.I.H., Extramural Conjeevaram HS, Kleiner DE, Everhart JE, Hoofnagle JH, Zacks S, Afdhal NH, Wahed AS. Race, insulin resistance and hepatic steatosis in chronic hepatitis C.  Hepatology  2007;45;1  Link to Race, insulin resistance and hepatic steatosis in chronic hepatitis C.

    28. 2006

  28. CommentLetter Hoofnagle JH. Overweight, obesity, and mortality.  N. Engl. J. Med.  2006;355;25  Link to Overweight, obesity, and mortality.
  29. Journal ArticleReview Hoofnagle JH, Seeff LB. Peginterferon and ribavirin for chronic hepatitis C.  N. Engl. J. Med.  2006;355;23  Link to Peginterferon and ribavirin for chronic hepatitis C.
  30. Letter Miller ME, Everhart JE, Hoofnagle JH. Epidemiologic research and the action plan for liver disease research.  Ann Epidemiol  2006;16;11  Link to Epidemiologic research and the action plan for liver disease research.
  31. Comparative StudyJournal ArticleMulticenter StudyResearch Support, N.I.H., ExtramuralResearch Support, N.I.H., IntramuralValidation Studies Fontana RJ, Kleiner DE, Bilonick R, Terrault N, Afdhal N, Belle SH, Jeffers LJ, Ramcharran D, Ghany MG, Hoofnagle JH. Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection.  Hepatology  2006;44;4  Link to Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection.
  32. Clinical ConferenceJournal ArticleReview LaRusso NF, Shneider BL, Black D, Gores GJ, James SP, Doo E, Hoofnagle JH. Primary sclerosing cholangitis: summary of a workshop.  Hepatology  2006;44;3  Link to Primary sclerosing cholangitis: summary of a workshop.
  33. Clinical TrialComparative StudyJournal ArticleMulticenter StudyResearch Support, N.I.H., ExtramuralResearch Support, N.I.H., Intramural Conjeevaram HS, Fried MW, Jeffers LJ, Terrault NA, Wiley-Lucas TE, Afdhal N, Brown RS, Belle SH, Hoofnagle JH, Kleiner DE, Howell CD. Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.  Gastroenterology  2006;131;2  Link to Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.
  34. Clinical TrialJournal ArticleResearch Support, N.I.H., Intramural Lutchman G, Promrat K, Kleiner DE, Heller T, Ghany MG, Yanovski JA, Liang TJ, Hoofnagle JH. Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvement.  Clin. Gastroenterol. Hepatol.  2006;4;8  Link to Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvement.
  35. Journal Article Hoofnagle JH. The National Commission on Digestive Diseases.  Hepatology  2006;44;1  Link to The National Commission on Digestive Diseases.
  36. Journal ArticleReview Seeff LB, Hoofnagle JH. Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity.  Oncogene  2006;25;27  Link to Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity.
  37. Journal ArticleReview Spaulding AC, Weinbaum CM, Lau DT, Sterling R, Seeff LB, Margolis HS, Hoofnagle JH. A framework for management of hepatitis C in prisons.  Ann. Intern. Med.  2006;144;10  Link to A framework for management of hepatitis C in prisons.
  38. News Hoofnagle JH, Miller ME. Progress on the action plan for liver disease research.  Hepatology  2006;43;5  Link to Progress on the action plan for liver disease research.
  39. Journal ArticleMulticenter StudyResearch Support, N.I.H., Extramural Shneider BL, Brown MB, Haber B, Whitington PF, Schwarz K, Squires R, Bezerra J, Shepherd R, Rosenthal P, Hoofnagle JH, Sokol RJ. A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000.  J. Pediatr.  2006;148;4  Link to A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000.
  40. Journal ArticleResearch Support, N.I.H., Intramural Perumalswami P, Kleiner DE, Lutchman G, Heller T, Borg B, Park Y, Liang TJ, Hoofnagle JH, Ghany MG. Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection.  Hepatology  2006;43;4  Link to Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection.
  41. Journal Article Hoofnagle JH, Sokol RJ. Neonatal screening for biliary atresia.  Hepatology  2006;43;4  Link to Neonatal screening for biliary atresia.
  42. CommentEditorial Hoofnagle JH. Hepatitis B--preventable and now treatable.  N. Engl. J. Med.  2006;354;10  Link to Hepatitis B--preventable and now treatable.

    43. 2005

  43. Journal Article Hoofnagle JH. AASLD 2005 Distinguished Service Award to Dr. Leonard B. Seeff.  Hepatology  2005;42;6  Link to AASLD 2005 Distinguished Service Award to Dr. Leonard B. Seeff.
  44. Journal Article Zakhari S, Hoofnagle JH. Research opportunities on alcohol and liver damage.  Hepatology  2005;42;6  Link to Research opportunities on alcohol and liver damage.
  45. News Hoofnagle JH. Hepatitis B.  Hepatology  2005;42;4  Link to Hepatitis B.
  46. CommentLetter Borg BB, Hoofnagle JH. Peginterferon Alfa-2b and ribavirin for 12 versus 24 weeks in HCV infection.  N. Engl. J. Med.  2005;353;11  Link to Peginterferon Alfa-2b and ribavirin for 12 versus 24 weeks in HCV infection.
  47. Journal ArticleReview Feld JJ, Hoofnagle JH. Mechanism of action of interferon and ribavirin in treatment of hepatitis C.  Nature  2005;436;7053  Link to Mechanism of action of interferon and ribavirin in treatment of hepatitis C.
  48. Journal Article Hoofnagle JH. Milk thistle and chronic liver disease.  Hepatology  2005;42;1  Link to Milk thistle and chronic liver disease.
  49. Journal Article Soza A, Heller T, Ghany M, Lutchman G, Jake Liang T, Germain J, Hsu HH, Park Y, Hoofnagle JH. Pilot study of interferon gamma for chronic hepatitis C.  J. Hepatol.  2005;43;1  Link to Pilot study of interferon gamma for chronic hepatitis C.
  50. News Hoofnagle JH. Primary sclerosing cholangitis.  Hepatology  2005;41;5  Link to Primary sclerosing cholangitis.
  51. Clinical TrialJournal ArticleMulticenter StudyRandomized Controlled Trial Hoofnagle JH. Peds-C.  Hepatology  2005;41;3  Link to Peds-C.

    52. 2004

  52. Journal ArticleReview Hoofnagle JH. Hepatocellular carcinoma: summary and recommendations.  Gastroenterology  2004;127;5 Suppl 1  Link to Hepatocellular carcinoma: summary and recommendations.
  53. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Mizukoshi E, Sidney J, Livingston B, Ghany M, Hoofnagle JH, Sette A, Rehermann B. Cellular immune responses to the hepatitis B virus polymerase.  J. Immunol.  2004;173;9  Link to Cellular immune responses to the hepatitis B virus polymerase.
  54. News Hoofnagle JH. Drug-induced liver injury network (DILIN).  Hepatology  2004;40;4  Link to Drug-induced liver injury network (DILIN).
  55. Journal Article Hoofnagle JH. After the doubling.  Hepatology  2004;40;2  Link to After the doubling.
  56. Journal Article Hoofnagle JH. Hepatobiliary pathophysiology study section.  Hepatology  2004;39;6  Link to Hepatobiliary pathophysiology study section.
  57. Journal Article Hoofnagle JH. Biliary Atresia Research Consortium (BARC).  Hepatology  2004;39;4  Link to Biliary Atresia Research Consortium (BARC).
  58. Journal ArticleReview Hoofnagle JH. Liver disease research funding.  Hepatology  2004;39;2  Link to Liver disease research funding.
  59. Clinical TrialJournal ArticleResearch Support, U.S. Gov't, P.H.S. Promrat K, Lutchman G, Uwaifo GI, Freedman RJ, Soza A, Heller T, Doo E, Ghany M, Premkumar A, Park Y, Liang TJ, Yanovski JA, Kleiner DE, Hoofnagle JH. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis.  Hepatology  2004;39;1  Link to A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis.

    60. 2003

  60. CommentJournal Article Heller T, Hoofnagle JH. Denying the wolf access to sheep's clothing.  J. Clin. Invest.  2003;112;3  Link to Denying the wolf access to sheep's clothing.
  61. Clinical TrialClinical Trial, Phase IClinical Trial, Phase IIJournal ArticleRandomized Controlled Trial Hoofnagle JH, Ghany MG, Kleiner DE, Doo E, Heller T, Promrat K, Ong J, Khokhar F, Soza A, Herion D, Park Y, Everhart JE, Liang TJ. Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin.  Hepatology  2003;38;1  Link to Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin.
  62. Journal Article Lau DT, Ma H, Lemon SM, Doo E, Ghany MG, Miskovsky E, Woods GL, Park Y, Hoofnagle JH. A rapid immunochromatographic assay for hepatitis B virus screening.  J. Viral Hepat.  2003;10;4  Link to A rapid immunochromatographic assay for hepatitis B virus screening.
  63. CommentLetter Soza A, Hoofnagle JH. Mortality rate during interferon alfa-ribavirin combination therapy of chronic hepatitis C.  Hepatology  2003;38;1  Link to Mortality rate during interferon alfa-ribavirin combination therapy of chronic hepatitis C.
  64. CommentEditorialReview Lutchman G, Hoofnagle JH. Viral kinetics in hepatitis C.  Hepatology  2003;37;6  Link to Viral kinetics in hepatitis C.
  65. Journal Article Brown RS, Russo MW, Lai M, Shiffman ML, Richardson MC, Everhart JE, Hoofnagle JH. A survey of liver transplantation from living adult donors in the United States.  N. Engl. J. Med.  2003;348;9  Link to A survey of liver transplantation from living adult donors in the United States.
  66. Consensus Development ConferenceConsensus Development Conference, NIHJournal ArticleReview Seeff LB, Hoofnagle JH. Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.  Clin Liver Dis  2003;7;1  Link to Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.
  67. Journal Article Promrat K, McDermott DH, Gonzalez CM, Kleiner DE, Koziol DE, Lessie M, Merrell M, Soza A, Heller T, Ghany M, Park Y, Alter HJ, Hoofnagle JH, Murphy PM, Liang TJ. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.  Gastroenterology  2003;124;2  Link to Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
  68. Journal Article Ghany MG, Kleiner DE, Alter H, Doo E, Khokar F, Promrat K, Herion D, Park Y, Liang TJ, Hoofnagle JH. Progression of fibrosis in chronic hepatitis C.  Gastroenterology  2003;124;1  Link to Progression of fibrosis in chronic hepatitis C.
  69. Journal ArticleReview Hoofnagle JH. Challenges in therapy of chronic hepatitis B.  J. Hepatol.  2003;39 Suppl 1  Link to Challenges in therapy of chronic hepatitis B.
  70. Case ReportsJournal Article Soza A, Lau DT, Khokhar MF, Conjeevaram H, Park Y, Hoofnagle JH. Resolution of chronic hepatitis B-associated autoimmune neutropenia with interferon-alpha therapy.  J. Pediatr. Gastroenterol. Nutr.  2003;36;1  Link to Resolution of chronic hepatitis B-associated autoimmune neutropenia with interferon-alpha therapy.

    71. 2002

  71. Journal Article Soza A, Everhart JE, Ghany MG, Doo E, Heller T, Promrat K, Park Y, Liang TJ, Hoofnagle JH. Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C.  Hepatology  2002;36;5  Link to Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C.
  72. Journal ArticleResearch Support, U.S. Gov't, P.H.S.Review Di Bisceglie AM, Hoofnagle JH. Optimal therapy of hepatitis C.  Hepatology  2002;36;5 Suppl 1  Link to Optimal therapy of hepatitis C.
  73. Journal ArticleReview Hoofnagle JH. Course and outcome of hepatitis C.  Hepatology  2002;36;5 Suppl 1  Link to Course and outcome of hepatitis C.
  74. Journal Article Seeff LB, Hoofnagle JH. National Institutes of Health Consensus Development Conference: management of hepatitis C: 2002.  Hepatology  2002;36;5 Suppl 1  Link to National Institutes of Health Consensus Development Conference: management of hepatitis C: 2002.
  75. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, Hoofnagle JH, Liang TJ, Alter H, Rehermann B. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.  J. Immunol.  2002;169;6  Link to Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.
  76. Journal Article Strader DB, Bacon BR, Lindsay KL, La Brecque DR, Morgan T, Wright EC, Allen J, Khokar MF, Hoofnagle JH, Seeff LB. Use of complementary and alternative medicine in patients with liver disease.  Am. J. Gastroenterol.  2002;97;9  Link to Use of complementary and alternative medicine in patients with liver disease.
  77. CongressesResearch Support, U.S. Gov't, P.H.S. Shiffman ML, Brown RS, Olthoff KM, Everson G, Miller C, Siegler M, Hoofnagle JH. Living donor liver transplantation: summary of a conference at The National Institutes of Health.  Liver Transpl.  2002;8;2  Link to Living donor liver transplantation: summary of a conference at The National Institutes of Health.

    78. 2001

  78. CommentEditorial Hoofnagle JH. Therapy for acute hepatitis C.  N. Engl. J. Med.  2001;345;20  Link to Therapy for acute hepatitis C.
  79. Comparative StudyJournal ArticleReview Seeff LB, Lindsay KL, Bacon BR, Kresina TF, Hoofnagle JH. Complementary and alternative medicine in chronic liver disease.  Hepatology  2001;34;3  Link to Complementary and alternative medicine in chronic liver disease.
  80. Journal Article Yeo AE, Ghany M, Conry-Cantilena C, Melpolder JC, Kleiner DE, Shih JW, Hoofnagle JH, Alter HJ. Stability of HCV-RNA level and its lack of correlation with disease severity in asymptomatic chronic hepatitis C virus carriers.  J. Viral Hepat.  2001;8;4  Link to Stability of HCV-RNA level and its lack of correlation with disease severity in asymptomatic chronic hepatitis C virus carriers.
  81. Journal ArticleResearch Support, U.S. Gov't, P.H.S.Review Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000--summary of a workshop.  Gastroenterology  2001;120;7  Link to Management of hepatitis B: 2000--summary of a workshop.
  82. Congresses Bissell DM, Gores GJ, Laskin DL, Hoofnagle JH. Drug-induced liver injury: mechanisms and test systems.  Hepatology  2001;33;4  Link to Drug-induced liver injury: mechanisms and test systems.

    83. 2000

  83. Journal ArticleReview Howell C, Jeffers L, Hoofnagle JH. Hepatitis C in African Americans: summary of a workshop.  Gastroenterology  2000;119;5  Link to Hepatitis C in African Americans: summary of a workshop.
  84. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Lau DT, Khokhar MF, Doo E, Ghany MG, Herion D, Park Y, Kleiner DE, Schmid P, Condreay LD, Gauthier J, Kuhns MC, Liang TJ, Hoofnagle JH. Long-term therapy of chronic hepatitis B with lamivudine.  Hepatology  2000;32;4 Pt 1  Link to Long-term therapy of chronic hepatitis B with lamivudine.
  85. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Baumert TF, Wellnitz S, Aono S, Satoi J, Herion D, Tilman Gerlach J, Pape GR, Lau JY, Hoofnagle JH, Blum HE, Liang TJ. Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C.  Hepatology  2000;32;3  Link to Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C.
  86. Journal Article Czaja AJ, Manns MP, McFarlane IG, Hoofnagle JH. Autoimmune hepatitis: the investigational and clinical challenges.  Hepatology  2000;31;5  Link to Autoimmune hepatitis: the investigational and clinical challenges.
  87. CommentJournal Article Doo E, Hoofnagle JH. Combination therapy of hepatitis B.  Gut  2000;46;4  Link to Combination therapy of hepatitis B.
  88. Consensus Development ConferenceConsensus Development Conference, NIHJournal ArticleReview Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. Pathogenesis, natural history, treatment, and prevention of hepatitis C.  Ann. Intern. Med.  2000;132;4  Link to Pathogenesis, natural history, treatment, and prevention of hepatitis C.

    89. 1999

  89. GuidelineJournal ArticlePractice Guideline Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WG, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston AL, Fainboim L, Heathcote J, Homberg JC, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RN, Maddrey WC, Manns MP, McFarlane IG, Meyer zum Büschenfelde KH, Zeniya M. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.  J. Hepatol.  1999;31;5  Link to International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.
  90. Case ReportsJournal Article Lau DT, Kleiner DE, Park Y, Di Bisceglie AM, Hoofnagle JH. Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy.  Gastroenterology  1999;117;5  Link to Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy.
  91. Clinical TrialControlled Clinical TrialJournal Article Lau DT, Miller KD, Detmer J, Kolberg J, Herpin B, Metcalf JA, Davey RT, Hoofnagle JH. Hepatitis G virus and human immunodeficiency virus coinfection: response to interferon-alpha therapy.  J. Infect. Dis.  1999;180;4  Link to Hepatitis G virus and human immunodeficiency virus coinfection: response to interferon-alpha therapy.
  92. Clinical TrialJournal ArticleRandomized Controlled Trial Reddy KR, Hoofnagle JH, Tong MJ, Lee WM, Pockros P, Heathcote EJ, Albert D, Joh T. Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group.  Hepatology  1999;30;3  Link to Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group.
  93. Clinical TrialControlled Clinical TrialJournal Article Lau DT, Doo E, Park Y, Kleiner DE, Schmid P, Kuhns MC, Hoofnagle JH. Lamivudine for chronic delta hepatitis.  Hepatology  1999;30;2  Link to Lamivudine for chronic delta hepatitis.
  94. Clinical TrialJournal ArticleMulticenter StudyResearch Support, U.S. Gov't, P.H.S. Everhart JE, Wei Y, Eng H, Charlton MR, Persing DH, Wiesner RH, Germer JJ, Lake JR, Zetterman RK, Hoofnagle JH. Recurrent and new hepatitis C virus infection after liver transplantation.  Hepatology  1999;29;4  Link to Recurrent and new hepatitis C virus infection after liver transplantation.
  95. CongressesJournal ArticleResearch Support, U.S. Gov't, P.H.S. Bacon BR, Powell LW, Adams PC, Kresina TF, Hoofnagle JH. Molecular medicine and hemochromatosis: at the crossroads.  Gastroenterology  1999;116;1  Link to Molecular medicine and hemochromatosis: at the crossroads.
  96. Journal Article Hoofnagle JH. Management of hepatitis C: current and future perspectives.  J. Hepatol.  1999;31 Suppl 1  Link to Management of hepatitis C: current and future perspectives.

    97. 1998

  97. Clinical TrialJournal ArticleResearch Support, U.S. Gov't, P.H.S. Marques AR, Lau DT, McKenzie R, Straus SE, Hoofnagle JH. Combination therapy with famciclovir and interferon-alpha for the treatment of chronic hepatitis B.  J. Infect. Dis.  1998;178;5  Link to Combination therapy with famciclovir and interferon-alpha for the treatment of chronic hepatitis B.
  98. Clinical TrialJournal Article Lau DT, Kleiner DE, Ghany MG, Park Y, Schmid P, Hoofnagle JH. 10-Year follow-up after interferon-alpha therapy for chronic hepatitis C.  Hepatology  1998;28;4  Link to 10-Year follow-up after interferon-alpha therapy for chronic hepatitis C.
  99. Journal Article Chia SC, Bergasa NV, Kleiner DE, Goodman Z, Hoofnagle JH, Di Bisceglie AM. Pruritus as a presenting symptom of chronic hepatitis C.  Dig. Dis. Sci.  1998;43;10  Link to Pruritus as a presenting symptom of chronic hepatitis C.
  100. Comparative StudyJournal ArticleResearch Support, U.S. Gov't, P.H.S. Zetterman RK, Belle SH, Hoofnagle JH, Lawlor S, Wei Y, Everhart J, Wiesner RH, Lake JR. Age and liver transplantation: a report of the Liver Transplantation Database.  Transplantation  1998;66;4  Link to Age and liver transplantation: a report of the Liver Transplantation Database.
  101. Comparative StudyJournal ArticleReview Hoofnagle JH. Therapy of viral hepatitis.  Digestion  1998;59;5  Link to Therapy of viral hepatitis.
  102. Comparative StudyJournal ArticleMulticenter StudyResearch Support, U.S. Gov't, P.H.S. Everhart JE, Lombardero M, Lake JR, Wiesner RH, Zetterman RK, Hoofnagle JH. Weight change and obesity after liver transplantation: incidence and risk factors.  Liver Transpl Surg  1998;4;4  Link to Weight change and obesity after liver transplantation: incidence and risk factors.
  103. Journal Article Silva AE, McMahon BJ, Parkinson AJ, Sjogren MH, Hoofnagle JH, Di Bisceglie AM. Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine.  Clin. Infect. Dis.  1998;26;4  Link to Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine.
  104. Journal Article Lau DT, Comanor L, Minor JM, Everhart JE, Wuestehube LJ, Hoofnagle JH. Statistical models for predicting a beneficial response to interferon-alpha in patients with chronic hepatitis B.  J. Viral Hepat.  1998;5;2  Link to Statistical models for predicting a beneficial response to interferon-alpha in patients with chronic hepatitis B.

    105. 1997

  105. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Everhart JE, Lombardero M, Detre KM, Zetterman RK, Wiesner RH, Lake JR, Hoofnagle JH. Increased waiting time for liver transplantation results in higher mortality.  Transplantation  1997;64;9  Link to Increased waiting time for liver transplantation results in higher mortality.
  106. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Dickson RC, Everhart JE, Lake JR, Wei Y, Seaberg EC, Wiesner RH, Zetterman RK, Pruett TL, Ishitani MB, Hoofnagle JH. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.  Gastroenterology  1997;113;5  Link to Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
  107. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Hoofnagle JH, Lombardero M, Wei Y, Everhart J, Wiesner R, Zetterman R, Yun AJ, Yang L, Kim JP. Hepatitis G virus infection before and after liver transplantation. Liver Transplantation Database.  Liver Transpl Surg  1997;3;6  Link to Hepatitis G virus infection before and after liver transplantation. Liver Transplantation Database.
  108. CommentLetter Hoofnagle JH, Everhart J. Dose-finding study of interferon alfa-n3 in hepatitis C.  Hepatology  1997;26;5  Link to Dose-finding study of interferon alfa-n3 in hepatitis C.
  109. Journal Article Marrone A, Shih JW, Nakatsuji Y, Alter HJ, Lau D, Vergalla J, Hoofnagle JH. Serum hepatitis G virus RNA in patients with chronic viral hepatitis.  Am. J. Gastroenterol.  1997;92;11  Link to Serum hepatitis G virus RNA in patients with chronic viral hepatitis.
  110. Clinical TrialJournal ArticleRandomized Controlled Trial Lau DT, Everhart J, Kleiner DE, Park Y, Vergalla J, Schmid P, Hoofnagle JH. Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa.  Gastroenterology  1997;113;5  Link to Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa.
  111. Consensus Development ConferenceConsensus Development Conference, NIHJournal ArticleReview Everhart JE, Stolar M, Hoofnagle JH. Management of hepatitis C: a national survey of gastroenterologists and hepatologists.  Hepatology  1997;26;3 Suppl 1  Link to Management of hepatitis C: a national survey of gastroenterologists and hepatologists.
  112. Consensus Development ConferenceJournal ArticleReview Alter HJ, Conry-Cantilena C, Melpolder J, Tan D, Van Raden M, Herion D, Lau D, Hoofnagle JH. Hepatitis C in asymptomatic blood donors.  Hepatology  1997;26;3 Suppl 1  Link to Hepatitis C in asymptomatic blood donors.
  113. Consensus Development ConferenceJournal ArticleReview Hoofnagle JH. Hepatitis C: the clinical spectrum of disease.  Hepatology  1997;26;3 Suppl 1  Link to Hepatitis C: the clinical spectrum of disease.
  114. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Shakil AO, Hadziyannis S, Hoofnagle JH, Di Bisceglie AM, Gerin JL, Casey JL. Geographic distribution and genetic variability of hepatitis delta virus genotype I.  Virology  1997;234;1  Link to Geographic distribution and genetic variability of hepatitis delta virus genotype I.
  115. Congresses Hoofnagle JH, Kresina T, Fuller RK, Lake JR, Lucey MR, Sorrell MF, Beresford TP. Liver transplantation for alcoholic liver disease: executive statement and recommendations. Summary of a National Institutes of Health workshop held December 6-7, 1996, Bethesda, Maryland.  Liver Transpl Surg  1997;3;3  Link to Liver transplantation for alcoholic liver disease: executive statement and recommendations. Summary of a National Institutes of Health workshop held December 6-7, 1996, Bethesda, Maryland.
  116. Journal ArticleMulticenter StudyResearch Support, U.S. Gov't, P.H.S. Belle SH, Porayko MK, Hoofnagle JH, Lake JR, Zetterman RK. Changes in quality of life after liver transplantation among adults. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database (LTD).  Liver Transpl Surg  1997;3;2  Link to Changes in quality of life after liver transplantation among adults. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database (LTD).
  117. Journal Article Kleiner DE, Gaffey MJ, Sallie R, Tsokos M, Nichols L, McKenzie R, Straus SE, Hoofnagle JH. Histopathologic changes associated with fialuridine hepatotoxicity.  Mod. Pathol.  1997;10;3  Link to Histopathologic changes associated with fialuridine hepatotoxicity.
  118. CommentEditorial Herion D, Hoofnagle JH. The interferon sensitivity determining region: all hepatitis C virus isolates are not the same.  Hepatology  1997;25;3  Link to The interferon sensitivity determining region: all hepatitis C virus isolates are not the same.
  119. Journal ArticleReview Hoofnagle JH, di Bisceglie AM. The treatment of chronic viral hepatitis.  N. Engl. J. Med.  1997;336;5  Link to The treatment of chronic viral hepatitis.
  120. Journal ArticleReview Hoofnagle JH, Lau D. New therapies for chronic hepatitis B.  J. Viral Hepat.  1997;4 Suppl 1  Link to New therapies for chronic hepatitis B.

    121. 1996

  121. Journal Article Mangia A, Chung YH, Hoofnagle JH, Birkenmeyer L, Mushahwar I, Di Bisceglie AM. Pathogenesis of chronic liver disease in patients with chronic hepatitis B virus infection without serum HBeAg.  Dig. Dis. Sci.  1996;41;12  Link to Pathogenesis of chronic liver disease in patients with chronic hepatitis B virus infection without serum HBeAg.
  122. Clinical TrialComparative StudyJournal ArticleRandomized Controlled Trial Hayashi PH, Beames MP, Kuhns MC, Hoofnagle JH, Di Bisceglie AM. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.  Am. J. Gastroenterol.  1996;91;11  Link to Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
  123. Clinical TrialJournal Article Hoofnagle JH, Lau D, Conjeevaram H, Kleiner D, Di Bisceglie AM. Prolonged therapy of chronic hepatitis C with ribavirin.  J. Viral Hepat.  1996;3;5  Link to Prolonged therapy of chronic hepatitis C with ribavirin.
  124. Comparative StudyJournal ArticleMulticenter StudyResearch Support, U.S. Gov't, P.H.S. Hoofnagle JH, Lombardero M, Zetterman RK, Lake J, Porayko M, Everhart J, Belle SH, Detre KM. Donor age and outcome of liver transplantation.  Hepatology  1996;24;1  Link to Donor age and outcome of liver transplantation.
  125. CongressesReview Balistreri WF, Grand R, Hoofnagle JH, Suchy FJ, Ryckman FC, Perlmutter DH, Sokol RJ. Biliary atresia: current concepts and research directions. Summary of a symposium.  Hepatology  1996;23;6  Link to Biliary atresia: current concepts and research directions. Summary of a symposium.
  126. CommentEditorial Hoofnagle JH, Lau D. Chronic viral hepatitis--benefits of current therapies.  N. Engl. J. Med.  1996;334;22  Link to Chronic viral hepatitis--benefits of current therapies.
  127. In VitroJournal ArticleResearch Support, U.S. Gov't, P.H.S. Rehermann B, Lau D, Hoofnagle JH, Chisari FV. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection.  J. Clin. Invest.  1996;97;7  Link to Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection.
  128. Clinical TrialComparative StudyJournal Article Bergasa NV, Jones A, Kleiner DE, Rabin L, Park Y, Wells MC, Hoofnagle JH. Pilot study of low dose oral methotrexate treatment for primary biliary cirrhosis.  Am. J. Gastroenterol.  1996;91;2  Link to Pilot study of low dose oral methotrexate treatment for primary biliary cirrhosis.
  129. Case ReportsJournal Article Shakil AO, Di Bisceglie AM, Hoofnagle JH. Seizures during alpha interferon therapy.  J. Hepatol.  1996;24;1  Link to Seizures during alpha interferon therapy.

    130. 1995

  130. Clinical TrialJournal ArticleRandomized Controlled Trial Di Bisceglie AM, Conjeevaram HS, Fried MW, Sallie R, Park Y, Yurdaydin C, Swain M, Kleiner DE, Mahaney K, Hoofnagle JH. Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.  Ann. Intern. Med.  1995;123;12  Link to Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.
  131. Consensus Development ConferenceJournal ArticleReview Shiffman ML, Jeffers L, Hoofnagle JH, Tralka TS. The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: a conference sponsored by the National Digestive Diseases Advisory Board.  Hepatology  1995;22;5  Link to The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: a conference sponsored by the National Digestive Diseases Advisory Board.
  132. EditorialReview Conjeevaram HS, Everhart JE, Hoofnagle JH. Predictors of a sustained beneficial response to interferon alfa therapy in chronic hepatitis C.  Hepatology  1995;22;4 Pt 1  Link to Predictors of a sustained beneficial response to interferon alfa therapy in chronic hepatitis C.
  133. Journal Article Conjeevaram HS, Hoofnagle JH, Austin HA, Park Y, Fried MW, Di Bisceglie AM. Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa.  Gastroenterology  1995;109;2  Link to Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa.
  134. Journal ArticleReview Fried MW, Hoofnagle JH. Therapy of hepatitis C.  Semin. Liver Dis.  1995;15;1  Link to Therapy of hepatitis C.
  135. Consensus Development ConferenceConsensus Development Conference, NIHJournal ArticleReview Hoofnagle JH, Carithers RL, Shapiro C, Ascher N. Fulminant hepatic failure: summary of a workshop.  Hepatology  1995;21;1  Link to Fulminant hepatic failure: summary of a workshop.

    136. 1994

  136. Journal Article Di Bisceglie AM, Bacon BR, Kleiner DE, Hoofnagle JH. Increase in hepatic iron stores following prolonged therapy with ribavirin in patients with chronic hepatitis C.  J. Hepatol.  1994;21;6  Link to Increase in hepatic iron stores following prolonged therapy with ribavirin in patients with chronic hepatitis C.
  137. Journal Article Simpson LH, Battegay M, Hoofnagle JH, Waggoner JG, Di Bisceglie AM. Hepatitis delta virus RNA in serum of patients with chronic delta hepatitis.  Dig. Dis. Sci.  1994;39;12  Link to Hepatitis delta virus RNA in serum of patients with chronic delta hepatitis.
  138. Clinical TrialComparative StudyControlled Clinical TrialJournal Article Mahaney K, Tedeschi V, Maertens G, Di Bisceglie AM, Vergalla J, Hoofnagle JH, Sallie R. Genotypic analysis of hepatitis C virus in American patients.  Hepatology  1994;20;6  Link to Genotypic analysis of hepatitis C virus in American patients.
  139. Journal Article Battegay M, Simpson LH, Hoofnagle JH, Sallie R, Di Bisceglie AM. Elimination of hepatitis delta virus infection after loss of hepatitis B surface antigen in patients with chronic delta hepatitis.  J. Med. Virol.  1994;44;4  Link to Elimination of hepatitis delta virus infection after loss of hepatitis B surface antigen in patients with chronic delta hepatitis.
  140. Journal Article Di Bisceglie AM, Simpson LH, Lotze MT, Hoofnagle JH. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection.  J. Clin. Gastroenterol.  1994;19;3  Link to Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection.
  141. Journal Article Shindo M, Di Bisceglie AM, Akatsuka T, Fong TL, Scaglione L, Donets M, Hoofnagle JH, Feinstone SM. The physical state of the negative strand of hepatitis C virus RNA in serum of patients with chronic hepatitis C.  Proc. Natl. Acad. Sci. U.S.A.  1994;91;18  Link to The physical state of the negative strand of hepatitis C virus RNA in serum of patients with chronic hepatitis C.
  142. Clinical TrialJournal ArticleRandomized Controlled Trial Fried MW, Fong TL, Swain MG, Park Y, Beames MP, Banks SM, Hoofnagle JH, Di Bisceglie AM. Therapy of chronic hepatitis B with a 6-month course of ribavirin.  J. Hepatol.  1994;21;2  Link to Therapy of chronic hepatitis B with a 6-month course of ribavirin.
  143. Journal ArticleReview Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging.  Hepatology  1994;19;6  Link to Classification of chronic hepatitis: diagnosis, grading and staging.
  144. Journal Article Fong TL, Di Bisceglie AM, Biswas R, Waggoner JG, Wilson L, Claggett J, Hoofnagle JH. High levels of viral replication during acute hepatitis B infection predict progression to chronicity.  J. Med. Virol.  1994;43;2  Link to High levels of viral replication during acute hepatitis B infection predict progression to chronicity.
  145. Comparative StudyJournal Article Shindo M, Di Bisceglie AM, Silver J, Limjoco T, Hoofnagle JH, Feinstone SM. Detection and quantitation of hepatitis C virus RNA in serum using the polymerase chain reaction and a colorimetric enzymatic detection system.  J. Virol. Methods  1994;48;1  Link to Detection and quantitation of hepatitis C virus RNA in serum using the polymerase chain reaction and a colorimetric enzymatic detection system.
  146. Comparative StudyJournal Article Silva AE, Hosein B, Boyle RW, Fang CT, Shindo M, Waggoner JG, Hoofnagle JH, Di Bisceglie AM. Diagnosis of chronic hepatitis C: comparison of immunoassays and the polymerase chain reaction.  Am. J. Gastroenterol.  1994;89;4  Link to Diagnosis of chronic hepatitis C: comparison of immunoassays and the polymerase chain reaction.
  147. Clinical TrialJournal ArticleRandomized Controlled Trial Teran JC, Mullen KD, Hoofnagle JH, McCullough AJ. Decrease in serum levels of markers of hepatic connective tissue turnover during and after treatment of chronic hepatitis B with interferon-alpha.  Hepatology  1994;19;4  Link to Decrease in serum levels of markers of hepatic connective tissue turnover during and after treatment of chronic hepatitis B with interferon-alpha.
  148. Journal ArticleReview Hoofnagle JH. Therapy of acute and chronic viral hepatitis.  Adv Intern Med  1994;39  Link to Therapy of acute and chronic viral hepatitis.

    149. 1993

  149. Journal Article Fong TL, Di Bisceglie AM, Gerber MA, Waggoner JG, Hoofnagle JH. Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B.  Hepatology  1993;18;6  Link to Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B.
  150. Clinical TrialComparative StudyJournal ArticleRandomized Controlled Trial Di Bisceglie AM, Fong TL, Fried MW, Swain MG, Baker B, Korenman J, Bergasa NV, Waggoner JG, Park Y, Hoofnagle JH. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.  Am. J. Gastroenterol.  1993;88;11  Link to A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.
  151. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Norman JE, Beebe GW, Hoofnagle JH, Seeff LB. Mortality follow-up of the 1942 epidemic of hepatitis B in the U.S. Army.  Hepatology  1993;18;4  Link to Mortality follow-up of the 1942 epidemic of hepatitis B in the U.S. Army.
  152. Comparative StudyJournal Article Di Bisceglie AM, Hoofnagle JH, Krawczynski K. Changes in hepatitis C virus antigen in liver with antiviral therapy.  Gastroenterology  1993;105;3  Link to Changes in hepatitis C virus antigen in liver with antiviral therapy.
  153. Clinical TrialComparative StudyJournal Article Hoofnagle JH, Di Bisceglie AM, Waggoner JG, Park Y. Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B.  Gastroenterology  1993;104;4  Link to Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B.
  154. Comparative StudyJournal Article Fried MW, Draguesku JO, Shindo M, Simpson LH, Banks SM, Hoofnagle JH, Di Bisceglie AM. Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis.  Dig. Dis. Sci.  1993;38;4  Link to Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis.
  155. Journal ArticleReview Hoofnagle JH, Di Bisceglie AM, Shindo M. Antiviral therapy of hepatitis C--present and future.  J. Hepatol.  1993;17 Suppl 3  Link to Antiviral therapy of hepatitis C--present and future.

    156. 1992

  156. CommentEditorial Everhart JE, Hoofnagle JH. Hepatitis B-related end-stage liver disease.  Gastroenterology  1992;103;5  Link to Hepatitis B-related end-stage liver disease.
  157. Clinical TrialJournal Article Fried MW, Korenman JC, Di Bisceglie AM, Park Y, Waggoner JG, Mitsuya H, Hartman NR, Yarchoan R, Broder S, Hoofnagle JH. A pilot study of 2',3'-dideoxyinosine for the treatment of chronic hepatitis B.  Hepatology  1992;16;4  Link to A pilot study of 2',3'-dideoxyinosine for the treatment of chronic hepatitis B.
  158. Journal Article Di Bisceglie AM, Shindo M, Fong TL, Fried MW, Swain MG, Bergasa NV, Axiotis CA, Waggoner JG, Park Y, Hoofnagle JH. A pilot study of ribavirin therapy for chronic hepatitis C.  Hepatology  1992;16;3  Link to A pilot study of ribavirin therapy for chronic hepatitis C.
  159. Journal Article Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR. Measurements of iron status in patients with chronic hepatitis.  Gastroenterology  1992;102;6  Link to Measurements of iron status in patients with chronic hepatitis.
  160. Journal Article Lisker-Melman M, Di Bisceglie AM, Usala SJ, Weintraub B, Murray LM, Hoofnagle JH. Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa.  Gastroenterology  1992;102;6  Link to Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa.
  161. Journal Article Shindo M, Di Bisceglie AM, Hoofnagle JH. Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon.  Hepatology  1992;15;6  Link to Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon.
  162. Journal Article Shindo M, Di Bisceglie AM, Hoofnagle JH. Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C.  Gastroenterology  1992;102;4 Pt 1  Link to Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C.
  163. Journal Article Fried MW, Shindo M, Fong TL, Fox PC, Hoofnagle JH, Di Bisceglie AM. Absence of hepatitis C viral RNA from saliva and semen of patients with chronic hepatitis C.  Gastroenterology  1992;102;4 Pt 1  Link to Absence of hepatitis C viral RNA from saliva and semen of patients with chronic hepatitis C.
  164. Clinical TrialControlled Clinical TrialJournal Article Bergasa NV, Talbot TL, Alling DW, Schmitt JM, Walker EC, Baker BL, Korenman JC, Park Y, Hoofnagle JH, Jones EA. A controlled trial of naloxone infusions for the pruritus of chronic cholestasis.  Gastroenterology  1992;102;2  Link to A controlled trial of naloxone infusions for the pruritus of chronic cholestasis.
  165. Journal Article Cristiano K, Di Bisceglie AM, Hoofnagle JH, Feinstone SM. Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets.  Arch. Virol. Suppl.  1992;4  Link to Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets.

    166. 1991

  166. Journal Article Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis.  Hepatology  1991;14;6  Link to Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis.
  167. CommentEditorial Hoofnagle JH, Bergasa NV. Methotrexate therapy of primary biliary cirrhosis: promising but worrisome.  Gastroenterology  1991;101;5  Link to Methotrexate therapy of primary biliary cirrhosis: promising but worrisome.
  168. Clinical TrialJournal ArticleRandomized Controlled Trial Shindo M, Di Bisceglie AM, Cheung L, Shih JW, Cristiano K, Feinstone SM, Hoofnagle JH. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C.  Ann. Intern. Med.  1991;115;9  Link to Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C.
  169. Clinical TrialControlled Clinical TrialJournal ArticleRandomized Controlled TrialResearch Support, U.S. Gov't, P.H.S. Mutchnick MG, Appelman HD, Chung HT, Aragona E, Gupta TP, Cummings GD, Waggoner JG, Hoofnagle JH, Shafritz DA. Thymosin treatment of chronic hepatitis B: a placebo-controlled pilot trial.  Hepatology  1991;14;3  Link to Thymosin treatment of chronic hepatitis B: a placebo-controlled pilot trial.
  170. Journal Article Fong TL, Shindo M, Feinstone SM, Hoofnagle JH, Di Bisceglie AM. Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C.  J. Clin. Invest.  1991;88;3  Link to Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C.
  171. Journal Article Hoofnagle JH. Thrombocytopenia during interferon alfa therapy.  JAMA  1991;266;6  Link to Thrombocytopenia during interferon alfa therapy.
  172. Journal Article Hamilton FA, Hoofnagle JH. Reports from the NIH DDDN. The First award.  Gastroenterology  1991;101;2  Link to Reports from the NIH DDDN. The First award.
  173. Journal Article Fong TL, Di Bisceglie AM, Waggoner JG, Banks SM, Hoofnagle JH. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B.  Hepatology  1991;14;1  Link to The significance of antibody to hepatitis C virus in patients with chronic hepatitis B.
  174. Journal Article Cristiano K, Di Bisceglie AM, Hoofnagle JH, Feinstone SM. Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets.  Hepatology  1991;14;1  Link to Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets.
  175. Journal Article Dale JK, Di Bisceglie AM, Hoofnagle JH, Straus SE. Chronic fatigue syndrome: lack of association with hepatitis C virus infection.  J. Med. Virol.  1991;34;2  Link to Chronic fatigue syndrome: lack of association with hepatitis C virus infection.
  176. Journal ArticleReview Peters M, Vierling J, Gershwin ME, Milich D, Chisari FV, Hoofnagle JH. Immunology and the liver.  Hepatology  1991;13;5  Link to Immunology and the liver.
  177. Case ReportsJournal ArticleReview Mullen KD, Hoofnagle JH, Jones EA. Shock wave-induced pancreatic trauma.  Am. J. Gastroenterol.  1991;86;5  Link to Shock wave-induced pancreatic trauma.
  178. Journal ArticleReview Hoofnagle JH, Di Bisceglie AM. Serologic diagnosis of acute and chronic viral hepatitis.  Semin. Liver Dis.  1991;11;2  Link to Serologic diagnosis of acute and chronic viral hepatitis.
  179. Journal Article Korenman J, Baker B, Waggoner J, Everhart JE, Di Bisceglie AM, Hoofnagle JH. Long-term remission of chronic hepatitis B after alpha-interferon therapy.  Ann. Intern. Med.  1991;114;8  Link to Long-term remission of chronic hepatitis B after alpha-interferon therapy.
  180. Journal Article Baker BL, Di Bisceglie AM, Kaneko S, Miller R, Feinstone SM, Waggoner JG, Hoofnagle JH. Determination of hepatitis B virus DNA in serum using the polymerase chain reaction: clinical significance and correlation with serological and biochemical markers.  Hepatology  1991;13;4  Link to Determination of hepatitis B virus DNA in serum using the polymerase chain reaction: clinical significance and correlation with serological and biochemical markers.
  181. CommentEditorial Di Bisceglie AM, Hoofnagle JH. Therapy of chronic hepatitis C with alpha-interferon: the answer? Or more questions?  Hepatology  1991;13;3  Link to Therapy of chronic hepatitis C with alpha-interferon: the answer? Or more questions?
  182. Journal Article Di Bisceglie AM, Order SE, Klein JL, Waggoner JG, Sjogren MH, Kuo G, Houghton M, Choo QL, Hoofnagle JH. The role of chronic viral hepatitis in hepatocellular carcinoma in the United States.  Am. J. Gastroenterol.  1991;86;3  Link to The role of chronic viral hepatitis in hepatocellular carcinoma in the United States.

    183. 1990

  183. Comparative StudyJournal Article Kaneko S, Miller RH, Di Bisceglie A, Feinstone SM, Hoofnagle JH, Purcell RH. Hepatitis B virus DNA detection and comparison with hepatitis B surface antigen.  Gastroenterol. Jpn.  1990;25 Suppl 2  Link to Hepatitis B virus DNA detection and comparison with hepatitis B surface antigen.
  184. Journal Article Kaneko S, Miller RH, Di Bisceglie AM, Feinstone SM, Hoofnagle JH, Purcell RH. Detection of hepatitis B virus DNA in serum by polymerase chain reaction. Application for clinical diagnosis.  Gastroenterology  1990;99;3  Link to Detection of hepatitis B virus DNA in serum by polymerase chain reaction. Application for clinical diagnosis.
  185. CommentEditorial Hoofnagle JH. Chronic hepatitis B.  N. Engl. J. Med.  1990;323;5  Link to Chronic hepatitis B.
  186. Journal Article Tsianos EV, Di Bisceglie AM, Papadopoulos NM, Costello R, Hoofnagle JH. Oligoclonal immunoglobulin bands in serum in association with chronic viral hepatitis.  Am. J. Gastroenterol.  1990;85;8  Link to Oligoclonal immunoglobulin bands in serum in association with chronic viral hepatitis.
  187. Journal Article Hoofnagle JH. Posttransfusion hepatitis B.  Transfusion  1990;30;5  Link to Posttransfusion hepatitis B.
  188. Comparative StudyJournal Article Kassianides C, Nussenblatt R, Palestine AG, Mellow SD, Hoofnagle JH. Liver injury from cyclosporine A.  Dig. Dis. Sci.  1990;35;6  Link to Liver injury from cyclosporine A.
  189. Journal ArticleReview Di Bisceglie AM, Hoofnagle JH. Antiviral therapy of chronic viral hepatitis. ACG Committee on FDA-Related Matters.  Am. J. Gastroenterol.  1990;85;6  Link to Antiviral therapy of chronic viral hepatitis. ACG Committee on FDA-Related Matters.
  190. Journal Article Tsianos EV, Hoofnagle JH, Fox PC, Alspaugh M, Jones EA, Schafer DF, Moutsopoulos HM. Sjögren's syndrome in patients with primary biliary cirrhosis.  Hepatology  1990;11;5  Link to Sjögren's syndrome in patients with primary biliary cirrhosis.
  191. Journal Article Yoo JY, Kim HY, Park CK, Khang SK, Jeong JW, Chung WK, Dibisceglie AM, Hoofnagle JH. Significance of hepatitis B core antigen in the liver in patients with chronic hepatitis B and its relation to hepatitis B virus DNA.  J. Gastroenterol. Hepatol.  1990;5;3  Link to Significance of hepatitis B core antigen in the liver in patients with chronic hepatitis B and its relation to hepatitis B virus DNA.
  192. Journal Article Everhart JE, Di Bisceglie AM, Murray LM, Alter HJ, Melpolder JJ, Kuo G, Hoofnagle JH. Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers.  Ann. Intern. Med.  1990;112;7  Link to Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers.
  193. Journal Article Kalser SC, Hoofnagle JH. Reports from the NIH DDDN. Human liver tissue for research.  Gastroenterology  1990;98;4  Link to Reports from the NIH DDDN. Human liver tissue for research.
  194. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Cupps TR, Hoofnagle JH, Ellis RW, Miller WJ, Gerin JL, Volkman DJ, Haas-Smith SA. In vitro immune responses to hepatitis B surface antigens S and preS2 during acute infection by hepatitis B virus in humans.  J. Infect. Dis.  1990;161;3  Link to In vitro immune responses to hepatitis B surface antigens S and preS2 during acute infection by hepatitis B virus in humans.
  195. Journal Article Murphy D, Hoofnagle JH. Reports from the NIH DDDN. Research training in digestive diseases.  Gastroenterology  1990;98;2  Link to Reports from the NIH DDDN. Research training in digestive diseases.
  196. Journal Article Di Bisceglie AM, Rustgi VK, Kassianides C, Lisker-Melman M, Park Y, Waggoner JG, Hoofnagle JH. Therapy of chronic hepatitis B with recombinant human alpha and gamma interferon.  Hepatology  1990;11;2  Link to Therapy of chronic hepatitis B with recombinant human alpha and gamma interferon.
  197. Journal Article Hoofnagle JH, Kalser SC. Reports from the NIH DDDN. Research support from the Division of Digestive Diseases and Nutrition.  Gastroenterology  1990;98;1  Link to Reports from the NIH DDDN. Research support from the Division of Digestive Diseases and Nutrition.
  198. Clinical TrialComparative StudyJournal ArticleRandomized Controlled Trial Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Goodman Z, Banks SM, Hoofnagle JH. A randomized, double-blind, placebo-controlled trial of recombinant human alpha-interferon therapy for chronic non-A, non-B (type C) hepatitis.  J. Hepatol.  1990;11 Suppl 1  Link to A randomized, double-blind, placebo-controlled trial of recombinant human alpha-interferon therapy for chronic non-A, non-B (type C) hepatitis.
  199. Journal Article Di Bisceglie AM, Martin P, Lisker-Melman M, Kassianides C, Korenman J, Bergasa NV, Baker B, Hoofnagle JH. Therapy of chronic delta hepatitis with interferon alfa-2b.  J. Hepatol.  1990;11 Suppl 1  Link to Therapy of chronic delta hepatitis with interferon alfa-2b.
  200. Clinical TrialJournal ArticleReview Hoofnagle JH. Alpha-interferon therapy of chronic hepatitis B. Current status and recommendations.  J. Hepatol.  1990;11 Suppl 1  Link to Alpha-interferon therapy of chronic hepatitis B. Current status and recommendations.

    201. 1989

  201. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Negro F, Bonino F, Di Bisceglie A, Hoofnagle JH, Gerin JL. Intrahepatic markers of hepatitis delta virus infection: a study by in situ hybridization.  Hepatology  1989;10;6  Link to Intrahepatic markers of hepatitis delta virus infection: a study by in situ hybridization.
  202. Journal Article Fisher B, Keenan AM, Garra BS, Steinberg SM, White DE, DiBisceglie AM, Hoofnagle JH, Yolles P, Rosenberg SA, Lotze MT. Interleukin-2 induces profound reversible cholestasis: a detailed analysis in treated cancer patients.  J. Clin. Oncol.  1989;7;12  Link to Interleukin-2 induces profound reversible cholestasis: a detailed analysis in treated cancer patients.
  203. Case ReportsJournal Article Martin P, Di Bisceglie AM, Kassianides C, Lisker-Melman M, Hoofnagle JH. Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection.  Gastroenterology  1989;97;6  Link to Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection.
  204. Clinical TrialJournal ArticleRandomized Controlled Trial Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, Banks SM, Hoofnagle JH. Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.  N. Engl. J. Med.  1989;321;22  Link to Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.
  205. Journal Article Di Bisceglie AM, Hoofnagle JH. Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B.  Cancer  1989;64;10  Link to Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B.
  206. CommentEditorial Hoofnagle JH. Toward universal vaccination against hepatitis B virus.  N. Engl. J. Med.  1989;321;19  Link to Toward universal vaccination against hepatitis B virus.
  207. Journal ArticleReview Renault PF, Hoofnagle JH. Side effects of alpha interferon.  Semin. Liver Dis.  1989;9;4  Link to Side effects of alpha interferon.
  208. Journal ArticleReview Hoofnagle JH, Jones EA. Therapy of chronic viral hepatitis: past, present, and future.  Semin. Liver Dis.  1989;9;4  Link to Therapy of chronic viral hepatitis: past, present, and future.
  209. Journal ArticleReview Hoofnagle JH, Di Bisceglie AM. Treatment of chronic type C hepatitis with alpha interferon.  Semin. Liver Dis.  1989;9;4  Link to Treatment of chronic type C hepatitis with alpha interferon.
  210. Journal Article Kassianides C, Hoofnagle JH, Miller RH, Doo E, Ford H, Broder S, Mitsuya H. Inhibition of duck hepatitis B virus replication by 2',3'-dideoxycytidine. A potent inhibitor of reverse transcriptase.  Gastroenterology  1989;97;5  Link to Inhibition of duck hepatitis B virus replication by 2',3'-dideoxycytidine. A potent inhibitor of reverse transcriptase.
  211. Journal Article Lisker-Melman M, Webb D, Di Bisceglie AM, Kassianides C, Martin P, Rustgi V, Waggoner JG, Park Y, Hoofnagle JH. Glomerulonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferon.  Ann. Intern. Med.  1989;111;6  Link to Glomerulonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferon.
  212. Journal ArticleReview Lisker-Melman M, Martin P, Hoofnagle JH. Conditions associated with hepatocellular carcinoma.  Med. Clin. North Am.  1989;73;4  Link to Conditions associated with hepatocellular carcinoma.
  213. Comparative StudyIn VitroJournal ArticleResearch Support, U.S. Gov't, P.H.S. Cupps TR, Hoofnagle JH, Ellis RW, Miller WJ, Seeff L, Guerrera A, Gerin JL, Haas-Smith SA. In vitro immune responses to hepatitis B surface antigen (Pre-S2 and S) following remote infection by hepatitis B virus in humans.  J. Clin. Immunol.  1989;9;3  Link to In vitro immune responses to hepatitis B surface antigen (Pre-S2 and S) following remote infection by hepatitis B virus in humans.
  214. Case ReportsJournal Article Lisker-Melman M, Hoofnagle JH. Phenytoin hepatotoxicity masked by corticosteroids.  Arch. Intern. Med.  1989;149;5  Link to Phenytoin hepatotoxicity masked by corticosteroids.
  215. In VitroJournal Article Dooley JS, Vergalla J, Hoofnagle JH, Zoon KC, Munson PJ, Jones EA. Specific binding of human alpha interferon to high-affinity cell-surface binding sites on peripheral blood mononuclear cells.  J. Lab. Clin. Med.  1989;113;5  Link to Specific binding of human alpha interferon to high-affinity cell-surface binding sites on peripheral blood mononuclear cells.
  216. Case ReportsJournal Article Hoofnagle JH. Type D (delta) hepatitis.  JAMA  1989;261;9  Link to Type D (delta) hepatitis.
  217. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Sokol RJ, Kim YS, Hoofnagle JH, Heubi JE, Jones EA, Balistreri WF. Intestinal malabsorption of vitamin E in primary biliary cirrhosis.  Gastroenterology  1989;96;2 Pt 1  Link to Intestinal malabsorption of vitamin E in primary biliary cirrhosis.
  218. Journal Article Di Bisceglie AM, Hoofnagle JH. Treatment of chronic type B hepatitis.  Cancer Detect. Prev.  1989;14;2  Link to Treatment of chronic type B hepatitis.

    219. 1988

  219. Journal ArticleReview Hoofnagle JH, Di Bisceglie AM, Lisker-Melman M, Kassianides C, Martin P. Management of post-transfusion hepatitis.  Transfus Med Rev  1988;2;4  Link to Management of post-transfusion hepatitis.
  220. Clinical TrialJournal ArticleRandomized Controlled Trial Hoofnagle JH, Peters M, Mullen KD, Jones DB, Rustgi V, Di Bisceglie A, Hallahan C, Park Y, Meschievitz C, Jones EA. Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B.  Gastroenterology  1988;95;5  Link to Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B.
  221. Case ReportsJournal Article Jones DB, Mullick FG, Hoofnagle JH, Baranski B. Reye's syndrome-like illness in a patient receiving amiodarone.  Am. J. Gastroenterol.  1988;83;9  Link to Reye's syndrome-like illness in a patient receiving amiodarone.
  222. Journal Article Williams AL, Hoofnagle JH. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis.  Gastroenterology  1988;95;3  Link to Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis.
  223. Journal ArticleReview Di Bisceglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM, Lotze MT. NIH conference. Hepatocellular carcinoma.  Ann. Intern. Med.  1988;108;3  Link to NIH conference. Hepatocellular carcinoma.

    224. 1987

  224. Journal Article Di Bisceglie AM, Waggoner JG, Hoofnagle JH. Hepatitis B virus deoxyribonucleic acid in liver of chronic carriers. Correlation with serum markers and changes associated with loss of hepatitis B e antigen after antiviral therapy.  Gastroenterology  1987;93;6  Link to Hepatitis B virus deoxyribonucleic acid in liver of chronic carriers. Correlation with serum markers and changes associated with loss of hepatitis B e antigen after antiviral therapy.
  225. Journal Article Yoo JY, Howard R, Waggoner JG, Hoofnagle JH. Peroxidase-anti-peroxidase detection of hepatitis B surface and core antigen in liver biopsy specimens from patients with chronic type B hepatitis.  J. Med. Virol.  1987;23;3  Link to Peroxidase-anti-peroxidase detection of hepatitis B surface and core antigen in liver biopsy specimens from patients with chronic type B hepatitis.
  226. Clinical TrialJournal Article Renault PF, Hoofnagle JH, Park Y, Mullen KD, Peters M, Jones DB, Rustgi V, Jones EA. Psychiatric complications of long-term interferon alfa therapy.  Arch. Intern. Med.  1987;147;9  Link to Psychiatric complications of long-term interferon alfa therapy.
  227. Journal Article Hoofnagle JH. Antiviral treatment of chronic type B hepatitis.  Ann. Intern. Med.  1987;107;3  Link to Antiviral treatment of chronic type B hepatitis.
  228. Journal ArticleReview Hoofnagle JH, Shafritz DA, Popper H. Chronic type B hepatitis and the "healthy" HBsAg carrier state.  Hepatology  1987;7;4  Link to Chronic type B hepatitis and the "healthy" HBsAg carrier state.
  229. Journal ArticleReview Popper H, Shafritz DA, Hoofnagle JH. Relation of the hepatitis B virus carrier state to hepatocellular carcinoma.  Hepatology  1987;7;4  Link to Relation of the hepatitis B virus carrier state to hepatocellular carcinoma.
  230. Editorial Davis GL, Hoofnagle JH. Reactivation of chronic hepatitis B virus infection.  Gastroenterology  1987;92;6  Link to Reactivation of chronic hepatitis B virus infection.
  231. Journal Article Rustgi VK, Jones DB, Dinarello CA, Hoofnagle JH. Lymphokines and bile secretion in the rat.  Liver  1987;7;3  Link to Lymphokines and bile secretion in the rat.
  232. Clinical TrialJournal ArticleRandomized Controlled Trial Sjogren MH, Hoofnagle JH, Waggoner JG. Effect of corticosteroid therapy on levels of antibody to hepatitis B core antigen in patients with chronic type B hepatitis.  Hepatology  1987;7;3  Link to Effect of corticosteroid therapy on levels of antibody to hepatitis B core antigen in patients with chronic type B hepatitis.
  233. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Seeff LB, Beebe GW, Hoofnagle JH, Norman JE, Buskell-Bales Z, Waggoner JG, Kaplowitz N, Koff RS, Petrini JL, Schiff ER. A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army.  N. Engl. J. Med.  1987;316;16  Link to A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army.
  234. In VitroJournal Article Jones DB, Rustgi VK, Kornhauser DM, Woods A, Quinn R, Hoofnagle JH, Jones EA. The disposition of 6-deoxyacyclovir, a xanthine oxidase-activated prodrug of acyclovir, in the isolated perfused rat liver.  Hepatology  1987;7;2  Link to The disposition of 6-deoxyacyclovir, a xanthine oxidase-activated prodrug of acyclovir, in the isolated perfused rat liver.
  235. Journal ArticleReview Rustgi VK, Hoofnagle JH. Viral hepatitis during pregnancy.  Semin. Liver Dis.  1987;7;1  Link to Viral hepatitis during pregnancy.
  236. Case ReportsJournal Article Gahl WA, Finkelstein JD, Mullen KD, Bernardini I, Martin JJ, Backlund P, Ishak KG, Hoofnagle JH, Mudd SH. Hepatic methionine adenosyltransferase deficiency in a 31-year-old man.  Am. J. Hum. Genet.  1987;40;1  Link to Hepatic methionine adenosyltransferase deficiency in a 31-year-old man.
  237. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Eichberg JW, Seeff LB, Lawlor DL, Buskell-Bales Z, Ishak K, Hoofnagle JH, Goldstein AL, Langloss JM. Effect of thymosin immunostimulation with and without corticosteroid immunosuppression on chimpanzee hepatitis B carriers.  J. Med. Virol.  1987;21;1  Link to Effect of thymosin immunostimulation with and without corticosteroid immunosuppression on chimpanzee hepatitis B carriers.

    238. 1986

  238. Journal Article Hoofnagle JH, Mullen KD, Jones DB, Rustgi V, Di Bisceglie A, Peters M, Waggoner JG, Park Y, Jones EA. Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report.  N. Engl. J. Med.  1986;315;25  Link to Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report.
  239. Clinical TrialJournal ArticleRandomized Controlled Trial Hoofnagle JH, Davis GL, Schafer DF, Peters M, Avigan MI, Pappas SC, Hanson RG, Minuk GY, Dusheiko GM, Campbell G. Randomized trial of chlorambucil for primary biliary cirrhosis.  Gastroenterology  1986;91;6  Link to Randomized trial of chlorambucil for primary biliary cirrhosis.
  240. Journal Article Peters M, Walling DM, Kelly K, Davis GL, Waggoner JG, Hoofnagle JH. Immunologic effects of interferon-alpha in man: treatment with human recombinant interferon-alpha suppresses in vitro immunoglobulin production in patients with chronic type B hepatitis.  J. Immunol.  1986;137;10  Link to Immunologic effects of interferon-alpha in man: treatment with human recombinant interferon-alpha suppresses in vitro immunoglobulin production in patients with chronic type B hepatitis.
  241. In VitroJournal Article Peters M, Ambrus JL, Zheleznyak A, Walling D, Hoofnagle JH. Effect of interferon-alpha on immunoglobulin synthesis by human B cells.  J. Immunol.  1986;137;10  Link to Effect of interferon-alpha on immunoglobulin synthesis by human B cells.
  242. In VitroJournal Article Avigan MI, Adamson G, Hoofnagle JH, Jones EA. The in vitro production of antibodies to mitochondrial antigens by peripheral blood mononuclear cells from patients with primary biliary cirrhosis.  Hepatology  1986;6;5  Link to The in vitro production of antibodies to mitochondrial antigens by peripheral blood mononuclear cells from patients with primary biliary cirrhosis.
  243. Case ReportsJournal Article Schaff Z, Hoofnagle JH, Grimley PM. Hepatic inclusions during interferon therapy in chronic viral hepatitis.  Hepatology  1986;6;5  Link to Hepatic inclusions during interferon therapy in chronic viral hepatitis.
  244. Journal Article Davis GL, Hoofnagle JH. Interferon in viral hepatitis: role in pathogenesis and treatment.  Hepatology  1986;6;5  Link to Interferon in viral hepatitis: role in pathogenesis and treatment.
  245. Journal Article Sjogren MH, Bancroft WH, Hoofnagle JH, Sosebee JL, Lemon SM. Clinical significance of low molecular weight (7-8S) immunoglobulin M antibody to hepatitis B core antigen in chronic hepatitis B virus infections.  Gastroenterology  1986;91;1  Link to Clinical significance of low molecular weight (7-8S) immunoglobulin M antibody to hepatitis B core antigen in chronic hepatitis B virus infections.
  246. Journal Article Minuk GY, Vergalla J, Hanson RG, Hoofnagle JH, Frank MM, Jones EA. Anticomplement receptor activity in the serum of patients with primary biliary cirrhosis.  Gut  1986;27;3  Link to Anticomplement receptor activity in the serum of patients with primary biliary cirrhosis.
  247. Clinical TrialJournal ArticleRandomized Controlled Trial Hanson RG, Peters MG, Hoofnagle JH. Effects of immunosuppressive therapy with prednisolone on B and T lymphocyte function in patients with chronic type B hepatitis.  Hepatology  1986;6;2  Link to Effects of immunosuppressive therapy with prednisolone on B and T lymphocyte function in patients with chronic type B hepatitis.
  248. Journal ArticleReview Hoofnagle JH, Schafer DF. Serologic markers of hepatitis B virus infection.  Semin. Liver Dis.  1986;6;1  Link to Serologic markers of hepatitis B virus infection.
  249. Comparative StudyJournal Article Jicha DL, Davis GL, Peters MG, Hoofnagle JH, Jones EA. Effects of recombinant human leukocyte interferon treatment of endogenous interferon production in patients with chronic type-B hepatitis.  J. Interferon Res.  1986;6;1  Link to Effects of recombinant human leukocyte interferon treatment of endogenous interferon production in patients with chronic type-B hepatitis.
  250. Case ReportsJournal Article James SP, Jones EA, Schafer DF, Hoofnagle JH, Varma RR, Strober W. Selective immunoglobulin A deficiency associated with primary biliary cirrhosis in a family with liver disease.  Gastroenterology  1986;90;2  Link to Selective immunoglobulin A deficiency associated with primary biliary cirrhosis in a family with liver disease.
  251. Clinical TrialJournal ArticleRandomized Controlled Trial Hoofnagle JH, Davis GL, Pappas SC, Hanson RG, Peters M, Avigan MI, Waggoner JG, Jones EA, Seeff LB. A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial.  Ann. Intern. Med.  1986;104;1  Link to A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial.
  252. Journal Article Dooley JS, Davis GL, Peters M, Waggoner JG, Goodman Z, Hoofnagle JH. Pilot study of recombinant human alpha-interferon for chronic type B hepatitis.  Gastroenterology  1986;90;1  Link to Pilot study of recombinant human alpha-interferon for chronic type B hepatitis.
  253. Journal Article Peters M, Walling DM, Waggoner J, Avigan MI, Sjogren M, Hoofnagle JH. Immune effects of alpha-interferon in chronic liver disease.  J. Hepatol.  1986;3 Suppl 2  Link to Immune effects of alpha-interferon in chronic liver disease.
  254. Journal Article Nicolle LE, Minuk GY, Postl B, Ling N, Madden DL, Hoofnagle JH. Cross-sectional seroepidemiologic study of the prevalence of cytomegalovirus and herpes simplex virus infection in a Canadian Inuit (Eskimo) community.  Scand. J. Infect. Dis.  1986;18;1  Link to Cross-sectional seroepidemiologic study of the prevalence of cytomegalovirus and herpes simplex virus infection in a Canadian Inuit (Eskimo) community.
  255. Clinical TrialComparative StudyJournal Article Hoofnagle JH. Therapy of chronic type B hepatitis with adenine arabinoside and adenine arabinoside monophosphate.  J. Hepatol.  1986;3 Suppl 2  Link to Therapy of chronic type B hepatitis with adenine arabinoside and adenine arabinoside monophosphate.
  256. Journal ArticleReview Peters M, Davis GL, Dooley JS, Hoofnagle JH. The interferon system in acute and chronic viral hepatitis.  Prog Liver Dis  1986;8  Link to The interferon system in acute and chronic viral hepatitis.

    257. 1985

  257. Journal Article Jahn CE, Schaefer EJ, Taam LA, Hoofnagle JH, Lindgren FT, Albers JJ, Jones EA, Brewer HB. Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification.  Gastroenterology  1985;89;6  Link to Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification.
  258. Journal Article Hoofnagle JH, Ponzetto A, Mathiesen LR, Waggoner JG, Bales ZB, Seeff LB. Serological diagnosis of acute viral hepatitis.  Dig. Dis. Sci.  1985;30;11  Link to Serological diagnosis of acute viral hepatitis.
  259. Journal Article Sjogren M, Hoofnagle JH. Immunoglobulin M antibody to hepatitis B core antigen in patients with chronic type B hepatitis.  Gastroenterology  1985;89;2  Link to Immunoglobulin M antibody to hepatitis B core antigen in patients with chronic type B hepatitis.
  260. Journal Article James SP, Jones EA, Hoofnagle JH, Strober W. Circulating activated B cells in primary biliary cirrhosis.  J. Clin. Immunol.  1985;5;4  Link to Circulating activated B cells in primary biliary cirrhosis.
  261. Case ReportsJournal Article Davis GL, Hoofnagle JH. Reactivation of chronic type B hepatitis presenting as acute viral hepatitis.  Ann. Intern. Med.  1985;102;6  Link to Reactivation of chronic type B hepatitis presenting as acute viral hepatitis.
  262. Journal Article Grimley PM, Davis GL, Kang YH, Dooley JS, Strohmaier J, Hoofnagle JH. Tubuloreticular inclusions in peripheral blood mononuclear cells related to systemic therapy with alpha-interferon.  Lab. Invest.  1985;52;6  Link to Tubuloreticular inclusions in peripheral blood mononuclear cells related to systemic therapy with alpha-interferon.
  263. Journal Article Minuk GY, Ling N, Postl B, Waggoner JG, Nicolle LE, Hoofnagle JH. The changing epidemiology of hepatitis B virus infection in the Canadian north.  Am. J. Epidemiol.  1985;121;4  Link to The changing epidemiology of hepatitis B virus infection in the Canadian north.
  264. Journal Article Hoofnagle JH, Davis GL, Hanson RG, Pappas SC, Peters MG, Avigan MI, Waggoner JG, Howard R, Jones EA, Straus SE. Treatment of chronic type B hepatitis with multiple ten-day courses of adenine arabinoside monophosphate.  J. Med. Virol.  1985;15;2  Link to Treatment of chronic type B hepatitis with multiple ten-day courses of adenine arabinoside monophosphate.
  265. Comparative StudyJournal Article Minuk GY, Angus M, Brickman CM, Lawley TJ, Frank MM, Hoofnagle JH, Jones EA. Abnormal clearance of immune complexes from the circulation of patients with primary sclerosing cholangitis.  Gastroenterology  1985;88;1 Pt 1  Link to Abnormal clearance of immune complexes from the circulation of patients with primary sclerosing cholangitis.
  266. Journal Article Pappas SC, Hoofnagle JH, Young N, Straus SE, Jones EA. Treatment of chronic non-A, non-B hepatitis wih acyclovir: pilot study.  J. Med. Virol.  1985;15;1  Link to Treatment of chronic non-A, non-B hepatitis wih acyclovir: pilot study.

    267. 1984

  267. Journal Article Rustgi VK, Hoofnagle JH, Gerin JL, Gelmann EP, Reichert CM, Cooper JN, Macher AM. Hepatitis B virus infection in the acquired immunodeficiency syndrome.  Ann. Intern. Med.  1984;101;6  Link to Hepatitis B virus infection in the acquired immunodeficiency syndrome.
  268. Comparative StudyJournal Article Ponzetto A, Hoofnagle JH, Seeff LB. Antibody to the hepatitis B virus-associated delta-agent in immune serum globulins.  Gastroenterology  1984;87;6  Link to Antibody to the hepatitis B virus-associated delta-agent in immune serum globulins.
  269. Case ReportsJournal Article Avigan MI, Ishak KG, Gregg RE, Hoofnagle JH. Morphologic features of the liver in abetalipoproteinemia.  Hepatology  1984;4;6  Link to Morphologic features of the liver in abetalipoproteinemia.
  270. Journal Article Ponzetto A, Seeff LB, Buskell-Bales Z, Ishak KG, Hoofnagle JH, Zimmerman HJ, Purcell RH, Gerin JL. Hepatitis B markers in United States drug addicts with special emphasis on the delta hepatitis virus.  Hepatology  1984;4;6  Link to Hepatitis B markers in United States drug addicts with special emphasis on the delta hepatitis virus.
  271. Journal Article Hanson RG, Hoofnagle JH, Minuk GY, Purcell RH, Gerin JL. Cell-mediated immunity to hepatitis B surface antigen in man.  Clin. Exp. Immunol.  1984;57;2  Link to Cell-mediated immunity to hepatitis B surface antigen in man.
  272. Journal Article Feinstone SM, Hoofnagle JH. Non-A, maybe-B hepatitis.  N. Engl. J. Med.  1984;311;3  Link to Non-A, maybe-B hepatitis.
  273. Journal Article Sjogren MH, Lemon SM, Chung WK, Sun HS, Hoofnagle JH. IgM antibody to hepatitis B core antigen in Korean patients with hepatocellular carcinoma.  Hepatology  1984;4;4  Link to IgM antibody to hepatitis B core antigen in Korean patients with hepatocellular carcinoma.
  274. Journal Article Davis GL, Hoofnagle JH, Waggoner JG. Spontaneous reactivation of chronic hepatitis B virus infection.  Gastroenterology  1984;86;2  Link to Spontaneous reactivation of chronic hepatitis B virus infection.
  275. Case ReportsJournal Article Davis GL, Hoofnagle JH, Waggoner JG. Acute type A hepatitis during chronic hepatitis B virus infection: association of depressed hepatitis B virus replication with appearance of endogenous alpha interferon.  J. Med. Virol.  1984;14;2  Link to Acute type A hepatitis during chronic hepatitis B virus infection: association of depressed hepatitis B virus replication with appearance of endogenous alpha interferon.
  276. Clinical TrialJournal ArticleRandomized Controlled Trial Hoofnagle JH, Hanson RG, Minuk GY, Pappas SC, Schafer DF, Dusheiko GM, Straus SE, Popper H, Jones EA. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis.  Gastroenterology  1984;86;1  Link to Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis.

    277. 1983

  277. Case ReportsLetter Sherertz RJ, Spindel E, Hoofnagle JH. Antibody to hepatitis B surface antigen may not always indicate immunity to hepatitis B virus infection.  N. Engl. J. Med.  1983;309;24  Link to Antibody to hepatitis B surface antigen may not always indicate immunity to hepatitis B virus infection.
  278. Journal Article Ferenci P, Schafer DF, Kleinberger G, Hoofnagle JH, Jones EA. Serum levels of gamma-aminobutyric-acid-like activity in acute and chronic hepatocellular disease.  Lancet  1983;2;8354  Link to Serum levels of gamma-aminobutyric-acid-like activity in acute and chronic hepatocellular disease.
  279. Journal ArticleResearch Support, U.S. Gov't, P.H.S. James SP, Hoofnagle JH, Strober W, Jones EA. NIH conference: Primary biliary cirrhosis: a model autoimmune disease.  Ann. Intern. Med.  1983;99;4  Link to NIH conference: Primary biliary cirrhosis: a model autoimmune disease.
  280. Comparative StudyJournal Article Wade JC, Gaffey M, Wiernik PH, Schimpff SC, Schiffer CA, Wesley M, Hoofnagle JH. Hepatitis in patients with acute nonlymphocytic leukemia.  Am. J. Med.  1983;75;3  Link to Hepatitis in patients with acute nonlymphocytic leukemia.
  281. Journal Article Minuk GY, Hoofnagle JH, McAuliffe VJ, Purcell RH. IgM antibody responses to hepatitis B surface antigen in recipients of hepatitis B virus vaccine.  J. Infect. Dis.  1983;148;2  Link to IgM antibody responses to hepatitis B surface antigen in recipients of hepatitis B virus vaccine.
  282. Journal Article Hoofnagle JH, Schafer DF, Ferenci P, Waggoner JG, Vergalla J, April M, Phillips L. Antibody to hepatitis B surface antigen in nonprimate animal species.  Gastroenterology  1983;84;6  Link to Antibody to hepatitis B surface antigen in nonprimate animal species.
  283. Case ReportsJournal Article Maturi MF, Fine JD, Schaffer EH, Minuk GY, Hoofnagle JH. Pyoderma gangrenosum associated with primary biliary cirrhosis.  Arch. Intern. Med.  1983;143;6  Link to Pyoderma gangrenosum associated with primary biliary cirrhosis.
  284. Journal Article Dusheiko GM, Hoofnagle JH, Cooksley WG, James SP, Jones EA. Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers.  J. Clin. Invest.  1983;71;5  Link to Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers.
  285. Journal Article Hoofnagle JH. Serodiagnosis of acute viral hepatitis.  Hepatology  1983;3;2  Link to Serodiagnosis of acute viral hepatitis.
  286. Journal Article Hoofnagle JH. Chronic type B hepatitis.  Gastroenterology  1983;84;2  Link to Chronic type B hepatitis.
  287. Journal Article Chung WK, Sun HS, Park DH, Minuk GY, Hoofnagle JH. Primary hepatocellular carcinoma and hepatitis B virus infection in Korea.  J. Med. Virol.  1983;11;2  Link to Primary hepatocellular carcinoma and hepatitis B virus infection in Korea.

    288. 1982

  288. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Minuk GY, Waggoner JG, Jernigan R, Nicolle LE, Postl B, Hoofnagle JH. Prevalence of antibody to hepatitis A virus in a Canadian Inuit community.  Can Med Assoc J  1982;127;9  Link to Prevalence of antibody to hepatitis A virus in a Canadian Inuit community.
  289. Journal Article Hoofnagle JH, Minuk GY, Dusheiko GM, Schafer DF, Johnson R, Straus S, Jones EA, Gerin JL, Ishak K. Adenine arabinoside 5'-monophosphate treatment of chronic type B hepatitis.  Hepatology  1982;2;6  Link to Adenine arabinoside 5'-monophosphate treatment of chronic type B hepatitis.
  290. Case ReportsJournal Article Minuk GY, Hoofnagle JH, Jones EA. Systemic side effects from the intrabiliary infusion of monooctanoin for the dissolution of gallstones.  J. Clin. Gastroenterol.  1982;4;2  Link to Systemic side effects from the intrabiliary infusion of monooctanoin for the dissolution of gallstones.
  291. Case ReportsJournal Article Hoofnagle JH, Dusheiko GM, Schafer DF, Jones EA, Micetich KC, Young RC, Costa J. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy.  Ann. Intern. Med.  1982;96;4  Link to Reactivation of chronic hepatitis B virus infection by cancer chemotherapy.
  292. Case ReportsLetter Minuk GY, Waggoner JG, Hoofnagle JH, Hanson RG, Pappas SC. Pipetter's thumb.  N. Engl. J. Med.  1982;306;12  Link to Pipetter's thumb.
  293. Journal Article Minuk GY, Nicolle LE, Postl B, Waggoner JG, Hoofnagle JH. Hepatitis virus infection in an isolated Canadian Inuit (Eskimo) population.  J. Med. Virol.  1982;10;4  Link to Hepatitis virus infection in an isolated Canadian Inuit (Eskimo) population.
  294. Journal Article Hoofnagle JH, Seeff LB. Natural history of chronic type B hepatitis.  Prog Liver Dis  1982;7  Link to Natural history of chronic type B hepatitis.

    295. 1981

  295. Journal ArticleReview Hoofnagle JH, Feinstone SM. Serological tests for non-A, non-B hepatitis: controversy.  Liver  1981;1;3  Link to Serological tests for non-A, non-B hepatitis: controversy.
  296. Journal Article Hoofnagle JH, Dusheiko GM, Seeff LB, Jones EA, Waggoner JG, Bales ZB. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis.  Ann. Intern. Med.  1981;94;6  Link to Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis.
  297. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Tabor E, Hoofnagle JH, Barker LF, Pineda-Tamondong G, Nath N, Smallwood LA, Gerety RJ. Antibody to hepatitis B core antigen in blood donors with a history of hepatitis.  Transfusion  1981;21;3  Link to Antibody to hepatitis B core antigen in blood donors with a history of hepatitis.
  298. Journal ArticleReview Hoofnagle JH. Type B hepatitis: virology, serology and clinical course.  Semin. Liver Dis.  1981;1;1  Link to Type B hepatitis: virology, serology and clinical course.
  299. Journal ArticleReview Hoofnagle JH. Serologic markers of hepatitis B virus infection.  Annu. Rev. Med.  1981;32  Link to Serologic markers of hepatitis B virus infection.
  300. Journal Article Hoofnagle JH. Precipitin system detected in sera from patients with non-A, non-B hepatitis.  J. Med. Virol.  1981;7;4  Link to Precipitin system detected in sera from patients with non-A, non-B hepatitis.

    301. 1980

  301. Case ReportsLetter Willis RM, Mulvihill JJ, Hoofnagle JH. Attempted suicide with purified aflatoxin.  Lancet  1980;1;8179  Link to Attempted suicide with purified aflatoxin.
  302. Journal Article Hoofnagle JH, Blake J, Buskell-Bales Z, Seeff LB. Lack of transmission of type B hepatitis by fiberoptic upper endoscopy.  J. Clin. Gastroenterol.  1980;2;1  Link to Lack of transmission of type B hepatitis by fiberoptic upper endoscopy.
  303. Journal Article Hoofnagle JH, Waggoner JG. Hepatitis A and B virus markers in immune serum globulin.  Gastroenterology  1980;78;2  Link to Hepatitis A and B virus markers in immune serum globulin.

    304. 1979

  304. Journal Article Hoofnagle JH, Seeff LB, Bales ZB, Wright EC, Zimmerman HJ. Passive-active immunity from hepatitis B immune globulin. Reanalysis of a Veterans Administration cooperative study of needle-stick hepatitis. The Veterans Administration Cooperative Study Group.  Ann. Intern. Med.  1979;91;6  Link to Passive-active immunity from hepatitis B immune globulin. Reanalysis of a Veterans Administration cooperative study of needle-stick hepatitis. The Veterans Administration Cooperative Study Group.
  305. Journal Article Tabor E, Hoofnagle JH, Smallwood LA, Drucker JA, Pineda-Tamondong GC, Ni LY, Greenwalt TJ, Barker LF, Gerety RJ. Studies of donors who transmit posttransfusion hepatitis.  Transfusion  1979;19;6  Link to Studies of donors who transmit posttransfusion hepatitis.
  306. Journal Article Hoofnagle JH. Current concepts in viral hepatitis.  Arq Gastroenterol  1979;16;3  Link to Current concepts in viral hepatitis.
  307. Journal Article Seeff LB, Hoofnagle JH. Immunoprophylaxis of viral hepatitis.  Gastroenterology  1979;77;1  Link to Immunoprophylaxis of viral hepatitis.
  308. Journal Article Hoofnagle JH. Prevention of type B hepatitis.  Gastroenterology  1979;76;6  Link to Prevention of type B hepatitis.

    309. 1978

  309. Clinical TrialJournal ArticleRandomized Controlled Trial Hoofnagle JH, Seeff LB, Bales ZB, Zimmerman HJ. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen.  N. Engl. J. Med.  1978;298;25  Link to Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen.
  310. Journal Article Alter HJ, Tabor E, Meryman HT, Hoofnagle JH, Kahn RA, Holland PV, Gerety RJ, Barker LF. Transmission of hepatitis V virus infection by transfusion of frozen-deglycerolized red blood cells.  N. Engl. J. Med.  1978;298;12  Link to Transmission of hepatitis V virus infection by transfusion of frozen-deglycerolized red blood cells.
  311. Case ReportsJournal Article Tabor E, Gerety RJ, Drucker JA, Seeff LB, Hoofnagle JH, Jackson DR, April M, Barker LF, Pineda-Tamondong G. Transmission of non-A, non-B hepatitis from man to chimpanzee.  Lancet  1978;1;8062  Link to Transmission of non-A, non-B hepatitis from man to chimpanzee.
  312. Journal Article Hoofnagle JH, Michalak T, Nowoslawski A, Gerety RJ, Barker LF. Immunofluorescence microscopy in experimentally induced, type B hepatitis in the chimpanzee.  Gastroenterology  1978;74;2 Pt 1  Link to Immunofluorescence microscopy in experimentally induced, type B hepatitis in the chimpanzee.
  313. Journal Article Bales ZB, Patterson JF, Hoofnagle JH, Seeff LB. Variation in gamma counter efficiency used in radioimmunoassay testing for hepatitis B surface antigen and antibody.  Transfusion  1978;18;1  Link to Variation in gamma counter efficiency used in radioimmunoassay testing for hepatitis B surface antigen and antibody.

    314. 1977

  314. Journal Article Hoofnagle JH, Gerety RJ, Tabor E, Feinstone SM, Barker LF, Purcell RH. Transmission of non-A, non-B hepatitis.  Ann. Intern. Med.  1977;87;1  Link to Transmission of non-A, non-B hepatitis.
  315. Journal Article Hoofnagle JH, Gerety RJ, Smallwood LA, Barker LF. Subtyping of hepatitis B surface antigen and antibody by radioimmunoassay.  Gastroenterology  1977;72;2  Link to Subtyping of hepatitis B surface antigen and antibody by radioimmunoassay.
  316. Journal Article Tabarestani M, Hoofnagle JH, Afkari A. Type B hepatitis in Iran.  Acta Med Iran  1977;20;3-4  Link to Type B hepatitis in Iran.

    317. 1976

  317. Case ReportsJournal Article Tabor E, Gerety RJ, Hoofnagle JH, Barker LF. Immune response in fulminant viral hepatitis, type B.  Gastroenterology  1976;71;4  Link to Immune response in fulminant viral hepatitis, type B.
  318. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Szmuness W, Hoofnagle JH, Stevens CE, Prince AM. Antibody against the hepatitis type B core antigen. A new tool for epidemiologic studies.  Am. J. Epidemiol.  1976;104;3  Link to Antibody against the hepatitis type B core antigen. A new tool for epidemiologic studies.
  319. Journal Article Dienstag JL, Schulman AN, Gerety RJ, Hoofnagle JH, Lorenz DE, Purcell RH, Barker LF. Hepatitis A antigen isolated from liver and stool: immunologic comparison of antisera prepared in guinea pigs.  J. Immunol.  1976;117;3  Link to Hepatitis A antigen isolated from liver and stool: immunologic comparison of antisera prepared in guinea pigs.
  320. Journal Article Hoofnagle JH, Gerety RJ, Thiel J, Barker LF. The prevalence of hepatitis B surface antigen in commercially prepared plasma products.  J. Lab. Clin. Med.  1976;88;1  Link to The prevalence of hepatitis B surface antigen in commercially prepared plasma products.
  321. Journal Article Schulman AN, Dienstag JL, Jackson DR, Hoofnagle JH, Gerety RJ, Purcell RH, Barker LF. Hepatitis A antigen particles in liver, bile, and stool of chimpanzees.  J. Infect. Dis.  1976;134;1  Link to Hepatitis A antigen particles in liver, bile, and stool of chimpanzees.
  322. Journal Article Pattison CP, Klein CA, Leger RT, Maynard JE, Berquist KR, Hoofnagle JH, Barker LF, Bryan JA, Smith DE. An outbreak of type B hepatitis associated with transfusion of plasma protein fraction.  Am. J. Epidemiol.  1976;103;4  Link to An outbreak of type B hepatitis associated with transfusion of plasma protein fraction.
  323. Journal Article Gerety RJ, Poplack DG, Hoofnagle JH, Blaese RM, Holland PV, Barker LF. Hepatitis B virus infection in the Wiskott-Aldrich syndrome.  J. Pediatr.  1976;88;4 Pt. 1  Link to Hepatitis B virus infection in the Wiskott-Aldrich syndrome.
  324. Journal Article Hoofnagle JH, Barker LF, Thiel J, Gerety RJ. Hepatitis B virus and hepatitis B surface antigen in human albumin products.  Transfusion  1976;16;2  Link to Hepatitis B virus and hepatitis B surface antigen in human albumin products.

    325. 1975

  325. Journal Article Dienstag JL, Feinstone SM, Purcell RH, Hoofnagle JH, Barker LF, London WT, Popper H, Peterson JM, Kapikian AZ. Experimental infection of chimpanzees with hepatitis A virus.  J. Infect. Dis.  1975;132;5  Link to Experimental infection of chimpanzees with hepatitis A virus.
  326. Journal Article Barker LF, Maynard JE, Purcell RH, Hoofnagle JH, Berquist KR, London WT, Gerety RJ, Krushak DH. Hepatitis B virus infection in chimpanzees: titration of subtypes.  J. Infect. Dis.  1975;132;4  Link to Hepatitis B virus infection in chimpanzees: titration of subtypes.
  327. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Szmuness W, Much I, Prince AM, Hoofnagle JH, Cherubin CE, Harley EJ, Block GH. On the role of sexual behavior in the spread of hepatitis B infection.  Ann. Intern. Med.  1975;83;4  Link to On the role of sexual behavior in the spread of hepatitis B infection.
  328. Journal Article Barker LF, Maynard JE, Purcell RH, Hoofnagle JH, Berquist KR, London WT. Viral hepatitis, type B, in experimental animals.  Am. J. Med. Sci.  1975;270;1  Link to Viral hepatitis, type B, in experimental animals.
  329. Comparative StudyJournal Article Gerety RJ, Hoofnagle JH, Nortman DF, Barker LF. Hepatitis B surface antigen (HBS Ag) subtypes and indices of clinical disease.  Gastroenterology  1975;68;5 Pt 1  Link to Hepatitis B surface antigen (HBS Ag) subtypes and indices of clinical disease.
  330. Journal Article Gerety RJ, Hoofnagle JH, Mitchell FD, Barker LF, Meyer HM. Evaluation of hepatitis B antigen testing in federally licensed blood banks in the United States.  Am. J. Clin. Pathol.  1975;63;4  Link to Evaluation of hepatitis B antigen testing in federally licensed blood banks in the United States.
  331. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Markenson JA, Daniels CA, Notkins AL, Hoofnagle JH, Gerety J, Barker LF. The interaction of rheumatoid factor with hepatitis B surface antigen-antibody complexes.  Clin. Exp. Immunol.  1975;19;2  Link to The interaction of rheumatoid factor with hepatitis B surface antigen-antibody complexes.
  332. Journal Article Markenson JA, Gerety RJ, Hoofnagle JH, Barker LF. Effects of cyclophosphamide on hepatitis B virus infection and challenge in chimpanzees.  J. Infect. Dis.  1975;131;2  Link to Effects of cyclophosphamide on hepatitis B virus infection and challenge in chimpanzees.

    333. 1974

  333. Clinical TrialComparative StudyJournal ArticleRandomized Controlled Trial Szmuness W, Prince AM, Hoofnagle JH, Ribot S, Jacobs MJ. Letter: Effectiveness of hepatitis-B immune globulin in haemodialysis patients.  Lancet  1974;2;7895  Link to Letter: Effectiveness of hepatitis-B immune globulin in haemodialysis patients.
  334. Journal Article Barker LF, Almeida JD, Hoofnagle JH, Gerety RJ, Jackson DR, McGrath PP. Hepatitis B core antigen: immunology and electron microscopy.  J. Virol.  1974;14;6  Link to Hepatitis B core antigen: immunology and electron microscopy.
  335. Journal Article Gerety RJ, Hoofnagle JH, Barker LF. Humoral and cell-mediated immune responses to two hepatitis B virus antigens in guinea pigs.  J. Immunol.  1974;113;4  Link to Humoral and cell-mediated immune responses to two hepatitis B virus antigens in guinea pigs.
  336. Journal Article Hoofnagle JH, Markenson JA, Daniels CA, Gerety RJ, Notkins AL, Barker LF. The lack of association between rheumatoid factor and hepatitis B antigen.  Am. J. Med. Sci.  1974;268;1  Link to The lack of association between rheumatoid factor and hepatitis B antigen.
  337. Journal Article Hoofnagle JH, Gerety RJ, Ni LY, Barker LF. Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis B virus replication.  N. Engl. J. Med.  1974;290;24  Link to Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis B virus replication.
  338. Journal Article Krugman S, Hoofnagle JH, Gerety RJ, Kaplan PM, Gerin JL. Viral hepatitis, type B, DNA polymerase activity and antibody to hepatitis B core antigen.  N. Engl. J. Med.  1974;290;24  Link to Viral hepatitis, type B, DNA polymerase activity and antibody to hepatitis B core antigen.
  339. Journal Article Gerety RJ, Hoofnagle JH, Markenson JA, Barker LF. Exposure to hepatitis B virus and development of the chronic HBAg carrier state in children.  J. Pediatr.  1974;84;5  Link to Exposure to hepatitis B virus and development of the chronic HBAg carrier state in children.
  340. Journal Article Johnson RA, Hoofnagle JH, Gerety RJ, Barker LF, Merchant B. Detection of cells producing antibody to hepatitis B surface antigen by an indirect hemolytic plaque assay.  Intervirology  1974;4;5  Link to Detection of cells producing antibody to hepatitis B surface antigen by an indirect hemolytic plaque assay.

    341. 1973

  341. Journal Article Hoofnagle JH, Gerety RJ, Barker LF. Antibody to hepatitis-B-virus core in man.  Lancet  1973;2;7834  Link to Antibody to hepatitis-B-virus core in man.
Back to page of Hoofnagle, Jay H..

Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.